Mayo Clinic Laboratory and pathology research roundup: December 27 - Insights
This week's research roundup features: Neuropathological findings in COVID-19: an autopsy cohort
Mayo Clinic Laboratory and pathology research roundup: February 21 - Insights
This week's Research Roundup features: Predicting amyloid PET and tau PET stages with plasma biomarkers.
Mayo Clinic Laboratory and pathology research roundup: November 29 - Insights
This week's research roundup features: AMPK: The key to ischemia-reperfusion injury
Mayo Clinic's Minnesota Campus Earns Top Score on 2018 Healthcare Equality Index - Insights
Mayo Clinic’s Minnesota campus has been recognized as a 2018 LGBTQ Healthcare Equality Leader, registering a top score of 100 from the Human Rights Campaign Foundation, a civil rights organization, on its 2018 Healthcare Equality Index.
Systems Engineering Archives - Insights
Skip to Content MayoACCESS MayoLINK...
Week in Review: April 1 - Insights
Today's Highlights Include: Walz signs ALS bill by senator with the disease, Health Fusion: A farm family's journey from tragedy to gratefulness through organ donation, and google Search will soon let you book checkups and other medical...
Week in Review: March 18 - Insights
Today's Highlights Include: A new strategy for staying one step ahead of the virus, Pfizer CEO says another Covid booster will be needed, and Senate votes to make daylight saving time permanent.
Week in Review: March 11 - Insights
Today's Highlights Include: MN has 14 hospitals in Newsweek's U.S. Top 500; Mayo best in the world, medical supplies head to Ukraine from Rochester, and how does your body react to stress?
Mayo Clinic Laboratory and pathology research roundup: December 14 - Insights
This week’s research roundup features: Renal Neoplasia in Polycystic Kidney Disease: An assessment of Tuberous Sclerosis complex-associated Renal Neoplasia and PKD1/TSC2 contiguous gene deletion syndrome.
Mayo Clinic Laboratory and pathology research roundup: January 11 - Insights
This week’s research roundup features: The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial.